Fri, Aug 1, 2014, 10:52 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Oramed Pharmaceuticals Inc. Message Board

  • assted assted Dec 26, 2013 8:13 AM Flag

    Aegis Capital

    From the press release: "Aegis Capital Corp. is acting as sole placement agent for the offering."

    This is the same Aegis Capital that recently initiated coverage of ORMP with a price target of $25.

    Ladies and gentlemen, you have been scammed.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • thats biotech-look at nwbo last month-anytime you have aridiculous runup in biotech it is usually followed by an offering-i will be curious to see if this bounces at 10-might today-good luck

      • 1 Reply to wavesearcher99
      • every successful growing company needs to raise funds by selling stock, especially when the stock is flying...last Friday it had just gone above 10...so how could anyone fault the company raising funds at $10 ? After all, there needs to be some preparation with investors to raise such funds...yes, its too bad that those who came in after it spiked to 15 on Wed. got caught in this...but, I doubt its the company's fault...the MMs likely got wind of the offering and raised the price so they could short it and make a quick buck...my feel is that it will recover quite quickly to 15 and above with another PR or so...

 
ORMP
8.04-0.29(-3.43%)Aug 1 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.